Factors such
as process miniaturization, high demand for lab automation equipment in drug
discovery and clinical diagnostics, higher reproducibility and accuracy, and
large workforce demand and supply gap are likely to drive the growth of lab
automation market. In addition, lab automation offers enhanced productivity and
reduced costs, better personnel safety, and small volumes of samples and
reagents.
Lab automation is defined as the use of technology to streamline or substitute
manual manipulation of equipment and processes. While an academic
research lab may prefer to use only some instruments in order to increase
productivity and reduce the time spent on a tedious task, a drug discovery unit
in a pharmaceutical company will perhaps need to automate all of its research
phases.
The global lab
automation market is expected to reach USD 5.20 Billion by 2022 from USD
4.06 Billion in 2017, at a CAGR of 5.1%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158
Global Lab Automation Market is Segmented on:
1. Equipment and Software
2. Applications
3. End Users
Equipment and Software:
The
automated workstation segment is expected to account for the largest share of
the lab automation market. The high demand for automation in liquid handling is
the key factor driving market growth in this segment. Automated workstations
offer advantages such as enhanced accuracy, and reduced time and cost.
Application of Lab Automation Market:
The lab automation market is segmented by application into drug discovery,
clinical diagnostics, genomics solutions, proteomics solutions, microbiology
solutions, and other applications. While the drug discovery segment held the largest
share of the market in 2017, the genomics solutions application segment is
expected to grow at the highest CAGR during the forecast period.
Lab automation products are adopted widely in genomics
for high-throughput requirements as automation provides greater reproducibility
and throughput compared to manual methods.
End Users:
The biotechnology & pharmaceutical companies end-user segment accounted
for the largest share of the market. This segment is also expected to grow at
the highest CAGR during the forecast period. Factors such as increasing product
intricacy, pricing pressure, and the need for consistency in quality are
driving biotechnology and pharmaceutical companies to adopt automation and
accelerate their drug discovery processes.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158
Key Players:
Tecan
Group (Switzerland), PerkinElmer (US), and Danaher (Beckman Coulter &
Molecular Devices) (US) are the leading players in lab automation market.
